Original Article

You have free access to this content

Role of endogenous testosterone concentration in pediatric stroke†

  1. Sandra Normann MD1,
  2. Gabrielle de Veber MD2,
  3. Manfred Fobker MD3,
  4. Claus Langer PhD3,
  5. Gili Kenet MD4,
  6. Timothy J. Bernard MD5,6,
  7. Barbara Fiedler MD7,
  8. Ronald Sträter MD1,
  9. Neil A. Goldenberg MD, PhD5,6,
  10. Ulrike Nowak-Göttl MD1,*

Article first published online: 21 AUG 2009

DOI: 10.1002/ana.21840

Issue

Annals of Neurology

Annals of Neurology

Volume 66, Issue 6, pages 754–758, December 2009

Additional Information

How to Cite

Normann, S., de Veber, G., Fobker, M., Langer, C., Kenet, G., Bernard, T. J., Fiedler, B., Sträter, R., Goldenberg, N. A. and Nowak-Göttl, U. (2009), Role of endogenous testosterone concentration in pediatric stroke. Ann Neurol., 66: 754–758. doi: 10.1002/ana.21840

Author Information

  1. 1

    Department of Pediatric Hematology/Oncology, University Children's Hospital, University of Münster, Münster,Germany

  2. 2

    Department of Neurology, Hospital for Sick Children, Toronto, Canada

  3. 3

    Department of Laboratory Medicine, University Hospital, Münster, Germany

  4. 4

    The Israel National Hemophilia Center, Sheba Medical Center, Tel-Hashomer, Israel

  5. 5

    The Mountain States Regional Hemophilia and Thrombosis Center, Department of Pediatrics, University of Colorado, Denver, CO

  6. 6

    The Children's Hospital, Aurora, CO

  7. 7

    Department of Pediatric Neurology, University Children's Hospital, Münster, Germany

*Pediatric Hematology/Oncology, University of Münster, Albert-Schweitzer-Str. 33, D-48149 Münster, Germany

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 23 DEC 2009
  2. Article first published online: 21 AUG 2009
  3. Accepted manuscript online: 21 AUG 2009 12:00AM EST
  4. Manuscript Accepted: 11 AUG 2009
  5. Manuscript Revised: 1 AUG 2009
  6. Manuscript Received: 18 MAY 2009

Funded by

  • Surveillance Unit of Rare Pediatric Diseases in Germany (ESPED, Supplementary Material)
  • Karl-Bröcker-Stiftung
  • Stiftung Deutsche Schlaganfall-Hilfe
  • Pediatric Stroke and Thrombosis Foundation e.V.
  • Career Development Award from the National Institutes of Health
  • National Heart Lung and Blood Institute. Grant Number: 1K23HL084055-01A1
  • National Centers for Research Resources. Grant Number: KL2RR025779

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (87K)

References

  • 1
    BondyPK, RosenbergLE, eds. Metabolic Control and Disease. 8th ed. Philadelphia, PA: W.B. Saunders; 1980: 1535–1578.
  • 2
    Carruthers M, Trinick TR, Wheeler MJ. The validity of androgen assays. Aging Male 2007; 10: 165–172.
  • 3
    Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD. Diurnal rhythms of serum total, free and bioavailable testosterone and SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf) 2003; 58: 710–717.
  • 4
    Golomb MR, Dick PT, MacGregor DL, et al. Neonatal arterial ischemic stroke and cerebral sinovenous thrombosis are more commonly diagnosed in boys. J Child Neurol 2004; 19: 493–497.
  • 5
    Salih MA, Abdel-Gader AG, Al-Jarallah AA, et al. Perinatal stroke in Saudi children. Clinical features and risk factors. Saudi Med J 2006; 27(suppl 1): S35–S40.
  • 6
    Fullerton HJ, Wu YW, Sidney S, Johnston SC. Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics 2007; 119: 495–501.
  • 7
    Golomb MR, Fullerton HJ, Nowak-Göttl U, deVeber G. Male predominance in childhood ischaemic stroke and cerebral sinovenous thrombosis: findings from the International Pediatric Stroke Study. Stroke 2009; 40: 52–57.
  • 8
    Sträter R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors for recurrent stroke during childhood—a 5-year follow-up study. Lancet 2002; 360: 1540–1545.
  • 9
    Bernard TJ, Goldenberg NA, Tripputi M, Manco-Johnson MJ, Niederstadt T, Nowak-Göttl U. Anticoagulation in childhood-onset arterial ischemic stroke with Nonmoyamoya arteriopathy: findings from the colorado and German (COAG) collaboration. Stroke 2009; 40: 2869–2871.
  • 10
    Kenet G, Kirkham F, Niederstadt T, et al. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurology 2007; 6: 595–603.
  • 11
    Tanner JM. Growth at Adolescence. 2nd ed. Oxford, UK: Blackwell Scientific Publications; 1962.
  • 12
    Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 76: F163–F167.
  • 13
    McNutt RA, Ferenchick GS, Kirlin PC, Hamlin NJ. Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol 1988; 62: 164.
  • 14
    Frankle MA, Eichberg R, Zachariah S. Anabolic-androgenic steroids and a stroke in an athlete: case report. Arch Phys Med Rehabil 1988; 69: 632–633.
  • 15
    Lowe GD, Thompson JE, Reavey MM, et al. Mesterolone: thrombosis during treatment and a study of its prothrombotic effects. Br J Clin Pharmacol 1979; 7: 107–109.
  • 16
    Shiozawa Z, Yamada H, Mabuchi C, et al. Superior sagittal sinus thrombosis associated with androgen therapy for hypoplastic anemia. Ann Neurol 1982; 12: 578–580.
  • 17
    Nagleberg SB, Lave L, Loriaux DL, et al. Cerebrovascular accident associated with testosterone therapy in a 21-year-old hypogonadal man. N Engl J Med 1986; 314: 645–650.
  • 18
    Pilo R, Aharony D, Raz A. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid and metabolism. Thromb Haemost 1981; 46: 538–542.
  • 19
    Winkler UH. Effects of androgens on haemostasis. Maturitas 1996; 24: 147–155.
  • 20
    Nakao J, Chang WC, Murotas I, Orimo H. Testosterone inhibits prostacyclin production by rat aortic smooth muscle cells in culture. Atherosclerosis 1981; 39: 203–209.
  • 21
    Pawlowitzki ICH, Diekstall P, Ming P, Balleisen L. Abnormal platelet function in Kallman syndrome. Lancet 1986; 8499: 166.
  • 22
    Anderson RA, Ludlam CA, Wu FCW. Haemostatic effects of supraphysiological levels of testosterone in normal men. Thromb Haemost 1995; 74: 693–697.
  • 23
    Taieb J, Mathian B, Millot F, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women and children. Clin Chem 2003; 49: 1381–1395.
View Full Article (HTML) Get PDF (87K)